Inaugural of BioInvest: (L-R) Dr K K Narayanan, Managing Director, Metahelix; Dr PM
Murali, CEO, Evolva Biotech & President, ABLE; Dr Jagdish Mittur, Head - Biotechnology
Facilitation Cell at KBITS and Dr D A Prassana, Chairman & MD, Ecron Acunova.
companies have come
up in the bio-ecosystem
in last one decade.
“Difficult circumstances,
especially for those who
started in 90s made
these companies to
adopt various models to
survive. More than half
of 1022 companies are
of 3-5 years of age which
shows the growth in last
few years. Yet the rest
half are the chunk that
survived the turbulent
years to come off as
today’s medium or big
companies,” he said while
adding that ABLE has
now started a mentoring
cell to guide startups. “I
expect these numbers
to cross 2000 mark by
2025,” said Dr Murali
while pointing towards
the need for doubling
the existing number of
companies. “Need to work
towards creating the right
environment, he said.
“I expect these numbers
to cross 2000 mark by
2025,” said Dr Murali
while pointing towards
the need for doubling
the existing number of
companies and need to
work towards creating
the right environment.
Dr Jagdish Mittur,
Head, Biotechnology
Facilitation Cell at KBITS,
Department of IT BT
and S&T, Government
BIOVOICENEWS.COM
47